Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eine Phase II Studie über Interferon Gamma 1b Zur Behandlung Der steroidrefraktären Bronchiolitis Obliterans Nach Allogener SZT

NCT01639261 is registered in ClinicalTrials.gov with University Hospital Regensburg as lead sponsor.

NCT NCT01639261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eine Phase II Studie über Interferon Gamma 1b Zur Behandlung Der steroidrefraktären Bronchiolitis Obliterans Nach Allogener SZT
Lead sponsor
University Hospital Regensburg
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2012
Completion date
September 30, 2014
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-refractory bronchiolitis obliterans